Trademarkia Logo

Canada

C$
HUFRAXTA
FORMALIZED

on 3 Apr 2025

Last Applicant/ Owned by

Larimar Therapeutics, Inc.

Three Bala Plaza East, Suite 506Bala Cynwyd PA 19004

US

Serial Number

2390300 filed on 6th Mar 2025

HUFRAXTA

Trademark usage description

pharmaceutical preparations; pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for Read More

Classification Information


Class [005]
Pharmaceutical preparations; pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's ataxia; pharmaceutical preparations for protein replacement therapy; pharmaceutical preparations for frataxin replacement therapy.


Classification kind code

12

Mark Details


Serial Number

2390300

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 3rd Apr 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 3rd Apr 2025
Created
Submitted for opposition 31
on 3rd Apr 2025
Formalized
Submitted for opposition 228
on 6th Mar 2025
International Registration
Submitted for opposition 30
on 6th Mar 2025
Filed